Stocks · US
BTSG
XNAS
BrightSpring Health Services, Inc. Common Stock
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E33.52x
P/B5.99x
P/S0.85x
EPS$1.85
ROE17.86%
ROA6.11%
Dividend yield0.00%
EV/EBITDA22.89x
Debt/Equity1.08
Free cash flow$402M
Returns and 52-week range
1W+14.47%
1M+4.97%
3M-9.57%
6M+45.32%
1Y+124.79%
YTD+66.02%
52W high$73.75
52W low$27.11
From 52W high-13.56%
Company
HeadquartersLouisville, KY
Employees23,500
Listed2024-01-26
Websitewww.brightspringhealth.com
SECFilings
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Halozyme Therapeutics, Inc. | $12.3B | 29.72 | 85.64 | -0.43% |
| Madrigal Pharmaceuticals, Inc. Common Stock | $11.4B | — | 21.78 | -8.25% |
| 페넘브라 | $12.5B | 77.78 | 8.16 | -1.59% |
| DaVita Inc. | $11.4B | 13.45 | — | -1.95% |
| Baxter International Inc. | $12.5B | — | 2.02 | -5.69% |
| Bio-Techne Corp. | $11.4B | 62.59 | 5.40 | +0.00% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.